Arch Biopartners(ACHFF)
$0.66-0.00 (-0.15%)
ACHFF
Arch Biopartners financials statements
$0.66
At close:-0.00 (-0.15%)
Arch Biopartners (ACHFF) Ratios
0 Followers
Arch Biopartners Ratios
ACHFF's free cash flow for Q3 2026 was C$-520.99K. For the 2026 fiscal year, ACHFF's free cash flow was increased by C$4.00 and operating cash flow was C$-520.99K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.03 | 0.18 | 0.20 | 0.22 | 0.84 |
| Quick Ratio | 0.03 | 0.18 | 0.20 | 0.22 | 0.84 |
| Cash Ratio | 0.00 | 0.00 | 0.14 | 0.18 | 0.14 |
| Solvency Ratio | -0.39 | -0.09 | -0.06 | -0.08 | -0.05 |
| Operating Cash Flow Ratio | -0.40 | -0.44 | -0.04 | -0.39 | -0.93 |
| Short-Term Operating Cash Flow Coverage | -0.56 | -0.84 | -0.05 | -0.51 | -1.65 |
| Net Current Asset Value | C$ -3.88M | C$ -4.35M | C$ -5.51M | C$ -4.47M | C$ -3.88M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 27.17 | 2.96 | 4.28 | 7.10 | 1.94 |
| Debt-to-Equity Ratio | -0.73 | -0.64 | -0.91 | -0.99 | -1.33 |
| Debt-to-Capital Ratio | -2.73 | -1.76 | -10.16 | -76.36 | 4.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.15 | -1.07 | -6.46 |
| Financial Leverage Ratio | -0.03 | -0.22 | -0.21 | -0.14 | -0.69 |
| Debt Service Coverage Ratio | -0.42 | -1.12 | -0.07 | -0.04 | -0.04 |
| Interest Coverage Ratio | -5.88 | -10.14 | -9.35 | -4.49 | -4.26 |
| Debt to Market Cap | 0.03 | 0.02 | 0.07 | 0.02 | 0.05 |
| Interest Debt Per Share | 0.05 | 0.05 | 0.09 | 0.08 | 0.09 |
| Net Debt to EBITDA | -2.19 | -0.78 | -12.46 | -38.68 | -61.23 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -78.05% | -6.50% | -52.14% | -3.86% |
| EBIT Margin | 0.00% | -166.40% | -162.90% | -113.92% | -23.05% |
| EBITDA Margin | 0.00% | -166.39% | -16.94% | -10.47% | -1.98% |
| Operating Profit Margin | 0.00% | -186.00% | -169.10% | -143.99% | -29.97% |
| Pretax Profit Margin | 0.00% | -184.74% | -167.69% | -145.95% | -30.10% |
| Net Profit Margin | 0.00% | -184.73% | -167.69% | -145.95% | -30.10% |
| Continuous Operations Profit Margin | 0.00% | -184.73% | -167.69% | -145.95% | -30.10% |
| Net Income Per EBT | 100.00% | 99.99% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 102.31% | 99.32% | 99.17% | 101.37% | 100.43% |
| Return on Assets (ROA) | -1485.45% | -418.98% | -284.07% | -226.50% | -43.85% |
| Return on Equity (ROE) | 40.00% | 90.16% | 60.38% | 31.49% | 30.14% |
| Return on Capital Employed (ROCE) | 39.10% | 90.78% | 69.81% | 64.37% | 223.71% |
| Return on Invested Capital (ROIC) | 145.70% | 250.18% | 679.66% | 2403.41% | -90.91% |
| Return on Tangible Assets | -1485.45% | -418.98% | -284.07% | -226.50% | -43.85% |
| Earnings Yield | -1.85% | -3.49% | -4.89% | -0.75% | -1.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 2.36 | 6.68 | 11.06 | 1.77 |
| Payables Turnover | 0.00 | 1.61 | 5.37 | 3.00 | 4.20 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 2.27 | 1.69 | 1.55 | 1.46 |
| Working Capital Turnover Ratio | 0.00 | -0.46 | -0.57 | -0.72 | -7.79 |
| Cash Conversion Cycle | 0.00 | -72.59 | -13.35 | -88.69 | 119.65 |
| Days of Sales Outstanding | 0.00 | 154.69 | 54.62 | 33.01 | 206.65 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 227.28 | 67.96 | 121.69 | 87.00 |
| Operating Cycle | 0.00 | 154.69 | 54.62 | 33.01 | 206.65 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.04 | -0.00 | -0.02 | -0.05 |
| Free Cash Flow Per Share | -0.02 | -0.04 | -0.00 | -0.02 | -0.05 |
| Dividend Paid and CapEx Coverage Ratio | -316817.00 | 0.00 | -46815.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -316817.00 | 0.00 | -46815.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.56 | -0.84 | -0.05 | -0.24 | -0.58 |
| Operating Cash Flow to Sales Ratio | 0.00 | -1.10 | -0.12 | -1.12 | -0.77 |
| Free Cash Flow Yield | -1.89% | -2.08% | -0.34% | -0.58% | -2.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -54.01 | -28.62 | -20.47 | -132.88 | -89.63 |
| Price-to-Sales (P/S) Ratio | 0.00 | 52.87 | 34.32 | 193.95 | 26.98 |
| Price-to-Book (P/B) Ratio | -21.63 | -25.80 | -12.36 | -41.85 | -27.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -53.01 | -48.12 | -290.87 | -173.23 | -35.18 |
| Price-to-Operating Cash Flow Ratio | -53.01 | -48.12 | -290.88 | -173.23 | -35.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.88 | -1.79 | -0.16 | -6.51 | 1.19 |
| Enterprise Value Multiple | -67.06 | -32.56 | -215.10 | -1891.14 | -1422.81 |
| Enterprise Value | 86.81M | 114.95M | 72.27M | 191.01M | 109.58M |
| EV to EBITDA | -67.06 | -32.56 | -215.10 | -1891.14 | -1422.81 |
| EV to Sales | 0.00 | 54.17 | 36.43 | 198.00 | 28.19 |
| EV to Free Cash Flow | -54.80 | -49.31 | -308.75 | -176.85 | -36.76 |
| EV to Operating Cash Flow | -54.80 | -49.31 | -308.76 | -176.85 | -36.76 |
| Tangible Book Value Per Share | -0.06 | -0.07 | -0.09 | -0.07 | -0.06 |
| Shareholders’ Equity Per Share | -0.06 | -0.07 | -0.09 | -0.07 | -0.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.03 | 0.03 | 0.02 | 0.06 |
| Net Income Per Share | -0.02 | -0.06 | -0.05 | -0.02 | -0.02 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.20 | 1.11 | 1.03 | 1.28 | 1.31 |
| Research & Development to Revenue | 0.00 | 1.72 | 0.98 | 1.32 | 0.97 |
| SG&A to Revenue | 0.00 | 0.82 | 1.37 | 0.78 | 0.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.99 | 0.03 | 0.03 |
| Income Quality | 1.02 | 0.00 | 0.07 | 1.00 | 2.55 |
Currency in CAD
